n-(2-chloroethyl)-n-nitrosoacetamide has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caillaud, D; Demidem, A; Madelmont, JC; Merle, P; Morvan, D | 1 |
| Finch, RA; Penketh, PG; Sartorelli, AC; Shyam, K | 1 |
| Barascut, JL; Bourut, C; Carminati, A; Chenut, E; Imbach, JL; Mathé, G | 1 |
3 other study(ies) available for n-(2-chloroethyl)-n-nitrosoacetamide and B16 Melanoma
| Article | Year |
|---|---|
CENU treatment induced bystander effects which are effective on parental and non-parental tumors and have a phospholipid metabolism proton NMR spectroscopy signature.
Topics: Animals; Bystander Effect; Carcinoma, Lewis Lung; Cell Differentiation; Ethylnitrosourea; Lung Neoplasms; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nitroso Compounds; Phospholipids; Protons | 2006 |
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
Topics: Animals; Antineoplastic Agents; Carmustine; Drug Screening Assays, Antitumor; Female; Humans; Hydrazines; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Nitroso Compounds; Prodrugs; Xenograft Model Antitumor Assays | 2001 |
On a new class of mixed-function drugs associating nitroimidazoles and CENU: the NICE-NU.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry, Physical; Leukemia L1210; Melanoma, Experimental; Mice; Nitroimidazoles; Nitroso Compounds; Structure-Activity Relationship | 1988 |